Cargando…

Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection

Immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is central to long-term control of the current pandemic. Despite our rapidly advancing knowledge of immune memory to SARS-CoV-2, understanding how these responses translate into protection against reinfection at both...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cromer, Deborah, Juno, Jennifer A., Khoury, David, Reynaldi, Arnold, Wheatley, Adam K., Kent, Stephen J., Davenport, Miles P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082486/ https://www.ncbi.nlm.nih.gov/pubmed/33927374 http://dx.doi.org/10.1038/s41577-021-00550-x

Ejemplares similares

Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast?
por: Kent, Stephen J., et al.
Publicado: (2022)

Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis
por: Cromer, Deborah, et al.
Publicado: (2022)

Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models
por: Khoury, David S., et al.
Publicado: (2020)

The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants
por: Koutsakos, Marios, et al.
Publicado: (2022)

Durable reprogramming of neutralizing antibody responses following Omicron breakthrough infection
por: Lee, Wen Shi, et al.
Publicado: (2023)

Preexisting immunity restricts mucosal antibody recognition of SARS-CoV-2 and Fc profiles during breakthrough infections
por: Selva, Kevin J., et al.
Publicado: (2023)

Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19
por: Wheatley, Adam K., et al.
Publicado: (2021)

Immune imprinting and SARS-CoV-2 vaccine design
por: Wheatley, Adam K., et al.
Publicado: (2021)

Tear antibodies to SARS‐CoV‐2: implications for transmission
por: Selva, Kevin J, et al.
Publicado: (2021)

Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis
por: Cromer, Deborah, et al.
Publicado: (2023)

SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses
por: Koutsakos, Marios, et al.
Publicado: (2023)

Decay of Fc-dependent antibody functions after mild to moderate COVID-19
por: Lee, Wen Shi, et al.
Publicado: (2021)

Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 Infection
por: Khoury, David S., et al.
Publicado: (2023)

The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study
por: Townsend, Jeffrey P, et al.
Publicado: (2021)

The First Case of Immunity Loss and SARS-CoV-2 Reinfection by the Same Virus Lineage in Amazonia
por: Ferrante, Lucas, et al.
Publicado: (2021)

SARS-CoV-2 reinfection()
por: Romera, I., et al.
Publicado: (2021)

Anti-Drug Antibodies in Pigtailed Macaques Receiving HIV Broadly Neutralising Antibody PGT121
por: Lee, Wen Shi, et al.
Publicado: (2021)

Reinfection and reactivation of SARS-CoV-2
por: Dowran, Razieh, et al.
Publicado: (2022)

SARS‐CoV‐2 Omicron variant: Characteristics and prevention
por: He, Xuemei, et al.
Publicado: (2021)

Superantigens and SARS-CoV-2
por: Hamdy, Adam, et al.
Publicado: (2022)

Improving Nasal Protection for Preventing SARS-CoV-2 Infection
por: Nocini, Riccardo, et al.
Publicado: (2022)

Reinfection With SARS-CoV-2: Implications for Vaccines
por: Cohen, Jeffrey I, et al.
Publicado: (2020)

Serological Markers of SARS-CoV-2 Reinfection
por: Siddiqui, Sameed M., et al.
Publicado: (2022)

Reinfection with SARS-CoV-2: An inconvenient truth?
por: Sonié, Pedro, et al.
Publicado: (2022)

Epidemiological assessment of SARS-CoV-2 reinfection
por: Almadhi, Marwa, et al.
Publicado: (2022)

Reinfection, recontamination and revaccination for SARS-CoV-2
por: Kullmann, Tamás, et al.
Publicado: (2022)

A case of SARS-CoV-2 reinfection in Ecuador
por: Prado-Vivar, Belén, et al.
Publicado: (2021)

Mathematical modeling and analysis of the SARS-Cov-2 disease with reinfection
por: Atifa, Asghar, et al.
Publicado: (2022)

The Importance and Challenges of Identifying SARS-CoV-2 Reinfections
por: Babiker, Ahmed, et al.
Publicado: (2021)

SARS-CoV-2 reinfection and COVID-19 severity
por: Nguyen, Nhu Ngoc, et al.
Publicado: (2022)

Determinants of reinfection with SARS-CoV-2 Omicron variant
por: Bisharat, N., et al.
Publicado: (2023)

Structural basis of biased T cell receptor recognition of an immunodominant HLA-A2 epitope of the SARS-CoV-2 spike protein
por: Chaurasia, Priyanka, et al.
Publicado: (2021)

mRNA Vaccination Induces Durable Immune Memory to SARS-CoV-2 with Continued Evolution to Variants of Concern
por: Goel, Rishi R., et al.
Publicado: (2021)

Reinfection with SARS-CoV-2: A case report from Libya
por: Teka, Ibrahim A., et al.
Publicado: (2021)

Polyphenols Could Prevent SARS-CoV-2 Infection by Modulating the Expression of miRNAs in the Host Cells
por: Milenkovic, Dragan, et al.
Publicado: (2021)

Reduced erythrocyte susceptibility and increased host clearance of young parasites slows Plasmodium growth in a murine model of severe malaria
por: Khoury, David S., et al.
Publicado: (2015)

Hydroxychloroquine for Treatment of SARS‐CoV‐2 Infection? Improving Our Confidence in a Model‐Based Approach to Dose Selection
por: Arnold, Samuel L.M., et al.
Publicado: (2020)

Instructing durable humoral immunity for COVID-19 and other vaccinable diseases
por: Bhattacharya, Deepta
Publicado: (2022)

Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domain
por: Wheatley, Adam K., et al.
Publicado: (2021)

Risk of SARS-CoV-2 reinfection after natural infection
por: Boyton, Rosemary J, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ojvilqmusm956okb3au7ahqf3o